RCSI_RespLab retweeted
Special Communication article by @UW McElvaney and @AccreditedCME McMahon discusses the challenges faced by international medical graduates aspiring to practice in the US at a time of worsening physician shortages and dwindling participation in academia. ja.ma/3xN4PH7
RCSI_RespLab retweeted
Thanks to Daniel Fraughen, MB, for his contribution to the November 1 issue
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline
@RCSI_Irl
@RCSI_Research
@Alpha1_Ireland
bit.ly/47cgPOi
RCSI_RespLab retweeted
@Alpha1_Ireland are attending the @irishthoracicS annual conference in Limerick today. Over 500 nurses, doctors, physiotherapists, and scientists active in respiratory medicine attending. A valuable opportunity to raise #Alpha1Awareness – at Limerick, Ireland
RCSI_RespLab retweeted
idonate.ie/fundraiser/Aplha1…
42klm a week in aid of @Alpha1_Ireland please donate
RCSI_RespLab retweeted
The Clinical Resources Section of HospitalBuddy has 100's of educational flashcards, infographics and educational pdfs! If you have handbooks you think we should add please email [email protected] - see these ITS cards in Respiratory Sectio- with thanks to @irishthoracicS
RCSI_RespLab retweeted
Congratulations to Tom, Michelle, and co-authors on this awesome work! Proud to have been a part of this study focusing on neutrophils in patients with obstructive lung disease.
@AJRCMB @RCSI_RespLab #almamater
atsjournals.org/doi/abs/10.1…
RCSI_RespLab retweeted
Congrats to Dr. Randy Curtis @uwpccm as the 2022 recipient of the American Thoracic Society’s Outstanding Clinician Award. This award is presented to an individual who has made substantial contributions in the clinical care of patients with lung disease. @UWMedicine – at Seattle, WA
RCSI_RespLab retweeted
HospitalBuddy Team want to congratulate all newly qualified doctors across the country; we have a database of intern& induction handbooks for across the country in our app-hope this helps along yer new journey @UCC_Medicine @UCCMedEd @ucdmedsoc @UCDMedicine @RcsiEmssi @NUIGMedSoc
RCSI_RespLab retweeted
Check out the new article on #MZ #Alpha1 in @ATSBlueEditor this month. Part of a Patient Education Series it is co-authored by Gerry Finnerty an Irish Alpha to improve readability for all. #PPI #Alpha1Awareness
Please like and RT. Read for free at bit.ly/35ITB8s
RCSI_RespLab retweeted
New issue! Bringing you a trial of the serine protease inhibitor alpha-1 antitrypsin as an anti-inflammatory therapeutic for patients with ARDS secondary to COVID-19, more research on Omicron, and a Commentary on AI in medicine.
RCSI_RespLab retweeted
WELCOME DERMOT!🔥@dburkephysio
We are thrilled to announce the appointment of our first:
National HSCP Fellow for Innovation - Dermot Burke 🤩 @WeHSCPs
A senior physiotherapist - Dermot joins us from @STMHDL !👏
@JackieAReed @HSCPsSVUH @JaredGormly @HIHIreland
RCSI_RespLab retweeted
#StandingUp4NCHDs Your @IHCA_IE and @IMO_IRL Consultant colleagues fully support you in looking to change the toxic culture and mistreatment that emanates from @roinnslainte and @HSELive
RCSI_RespLab retweeted
NCHDs are the unacknowledged backbone of our health service. I remember the last NCHD strike - morale has never been lower. These are dedicated individuals who already put up with more than any other public servant would - not sustainable
#StandingUp4NCHDs
RCSI_RespLab retweeted
This work was a true collaborative effort featuring work from an amazing team of colleagues! @CReM_Boston @hjhjess @RhiannonWerder @cvillamar @Kottond @CarlaKimLab @JGSdA @carogar7
RCSI_RespLab retweeted
ONLINE NOW: McElvaney et al present the results of a randomized trial of alpha-1 antitrypsin for patients with acute respiratory distress syndrome secondary to COVID-19. Circulating IL-6 and other pro-inflammatory markers were decreased at one week in the treatment group.
RCSI_RespLab retweeted
In @NatureBiotech excellent collaboration with @KleinLabHMS developing tools to predict cell fate decisions -led by @ShouwenW & using data from our @CellStemCell paper @MichaelHerriges in @Kottond & our group @LabHurley helped to validate predictions @TissueEngDublin @CReM_Boston
CoSpar with @KleinLabHMS is out at Nature Biotech! CoSpar robustly infers cell fate choice by integrating transcriptome and lineage tracing information. It reveals early fate bias across hematopoiesis, reprogramming, and directed differentiation. Link: rdcu.be/cHsqT
RCSI_RespLab retweeted
HospitalBuddy is delighted to launch our new website HospitalBuddy.ie where one can print out 100's of helpful free patient education leaflets for our patients without any login requirements @NDTP_HSE @RCPI_news @UCCMedHealth @RCSI_RespLab @RCPINCHDforum @rcpsych
RCSI_RespLab retweeted
Replying to @HospitalBuddy
@HospitalBuddy delivers Digital Solution by @OisinO_Connell - Read now: hospitalprofessionalnews.ie/…
RCSI_RespLab retweeted
Thrilled to see our review on the effect of effective #CFTR modulation on interleukin-8 in cystic fibrosis published in Expert Review of Respiratory Medicine 🥳🤩 @RCSI_RespLab @RCSI_Irl @RCSI_Research tandfonline.com/doi/full/10.…



































